| Literature DB >> 29302995 |
Qihong Zhang1, Nikolay E Polyakov2, Yulia S Chistyachenko3, Mikhail V Khvostov4,5, Tatjana S Frolova4,5,6, Tatjana G Tolstikova4,5, Alexandr V Dushkin3,7, Weike Su1,7.
Abstract
An amorphous solid dispersion (SD) of curcumin (Cur) with disodium glycyrrhizin (Na2GA) was prepared by mechanical ball milling. Curcumin loaded micelles were self-formed by Na2GA when SD dissolved in water. The physical properties of Cur SD in solid state were characterized by differential scanning calorimetry, X-ray diffraction studies, and scanning electron microscope. The characteristics of the sample solutions were analyzed by reverse phase HPLC, UV-visible spectroscopy, 1H NMR spectroscopy, gel permeation LC, and transmission electron microscopy. In vitro cytotoxic tests demonstrated that Cur SD induced higher cytotoxicity against glioblastoma U-87 MG cells than free Cur. Besides, an improvement of membrane permeability of Cur SD was confirmed by parallel artificial membrane permeability assay. Further pharmacokinetic study of this SD formulation in rat showed a significant ∼19-fold increase of bioavailability as comparing to free Cur. Thus, Cur SD provide a more potent and efficacious formulation for Cur oral delivery.Entities:
Keywords: Mechanical ball milling; bioavailability; curcumin; cytotoxic activity; self-micelle; solid dispersion
Mesh:
Substances:
Year: 2018 PMID: 29302995 PMCID: PMC6058497 DOI: 10.1080/10717544.2017.1422298
Source DB: PubMed Journal: Drug Deliv ISSN: 1071-7544 Impact factor: 6.419
Figure 1.(a) Structure and tautomerism of curcumin molecules; (b) DSC thermograms and (c) X-ray diffractograms of: A: curcumin; B: Na2GA; C: physical mixture (PM); D: Cur SD (molar ratio 1/2, milling 2 h); E: Cur SD (molar ratio 1/2, milling 24 h); electron micrographs of: (d) curcumin; (e) Na2GA; (f) Cur SD (molar ratio 1/2, milling 2 h); (g) Cur SD (molar ratio 1/2, milling 24 h).
Molecular weight distribution , size and zeta-potential of Cur SD in water solution.
| Samples | Cur/Na2GA, 1/1 | Cur/Na2GA, 1/2 | Cur/Na2GA, 1/4 |
|---|---|---|---|
| 83.7/85.0 | 85.0/87.9 | 88.3/88.5 | |
| 85.9/87.1 | 87.2/90.2 | 90.6/90.8 | |
| 79.3/80.9 | 80.6/84.8 | 84.8/84.8 | |
| Size (nm), 2 h/24 h | 43.83 ± 2.2/85.40 ± 4.5 | 46.20 ± 0.8/91.9 ± 6.0 | 71.4 ± 0.7/135.3 ± 7.9 |
| PI, 2 h/24 h | 0.272 ± 0.020/0.161 ± 0.013 | 0.241 ± 0.028/0.312 ± 0.001 | 0.319 ± 0.011/0.252 ± 0.009 |
| Zeta-potential (mV), 2 h/24 h | –37.7 ± 0.7/–38.6 ± 2.2 | –37.6 ± 0.6/–38.9 ± 1.6 | –39.6 ± 1.2/–43.5 ± 0.9 |
| Thermodynamic values (+37 °C, | |||
| Slope | 0.064 ± 0.0024 | 0.118 ± 0.0019 | 0.064 ± 0.0018 |
| 0.096 ± 0.026 | 0.188 ± 0.021 | 0.214 ± 0.020 | |
| 703.6 ± 195.4 | 713.2 ± 81.8 | 320.1 ± 30.6 | |
| Δ | –16.9 ± 0.7 | –16.9 ± 0.3 | –14.9 ± 0.2 |
M n: number average molecular weight; M w: weight average molecular weight; M p: molecular weight at peak maximum of the elution diagram.
Figure 3.Cytotoxic effects of pure Cur and Cur SDs on (a) MCF-7 cells; (b) U-87 MG cells; (c) immortalized human fibroblast cells, results are presented as mean viability ± SEM; (d) permeation profile of pure Cur and Cur SDs in PAMPA experiment; (e) concentration of curcumin in rat plasma after a single oral dose of 150 mg/kg of free Cur or Cur SD, *p < .05 compared to pure Cur in same point, **p < .01 compared to pure Cur in same point, values are mean ± SEM (n = 5).
Cytotoxicity of Na2GA in MCF-7, U-87 MG and immortalized human fibroblasts cell lines.
| Viability, % | |||
|---|---|---|---|
| Concentrationof Na2GA, μM | MCF-7 | U-87 MG | Immortalized human fibroblasts |
| 25 | 98.2 ± 2.13 | 96.6 ± 2.39 | 96.2 ± 2.78 |
| 50 | 97.8 ± 3.33 | 95.9 ± 1.16 | 97.3 ± 1.73 |
| 100 | 98.2 ± 0.41 | 92.2 ± 2.75 | 98.8 ± 4.18 |
| 200 | 98.7 ± 1.59 | 92.2 ± 2.63 | 96.0 ± 1.66 |
| 400 | 99.6 ± 1.34 | 92.9 ± 1.65 | 98.3 ± 0.90 |
Values are presented as mean viability ± SEM.
Pharmacokinetic parameters of curcumin following oral administration of free Cur and Cur SD.
| Parameters | Free Cur (control) | Cur SD 1:1 | Cur SD 1:2 | Cur SD 1:4 |
|---|---|---|---|---|
| 1.48 ± 0.03 | 9.04 ± 0.35 | 17.68 ± 0.22 | 29.87 ± 2.71 | |
| 15 ± 0.00 | 5 ± 0.00 | 5 ± 0.00 | 15 ± 0.00 | |
| 5.07 ± 0.41 | 8.02 ± 0.70 | 9.05 ± 0.65 | 11.16 ± 1.03 | |
| AUC0→ | 12.12 ± 0.36 | 64.50 ± 3.12 | 108.16 ± 5.2 | 231.61 ± 10.15 |
| AUC0→inf (μg/mL.h) | 14.26 ± 0.72 | 104.38 ± 6.21 | 181.60 ± 8.76 | 279.50 ± 12.11 |
AUC: area under the plasma concentration–time curve; C max: peak concentration; T max: time to reach peak concentration.
Values are reported as mean ± SEM (n = 5).
p < .01 compared with the control.